SCHEMBL6606026

SCHEMBL6606026

Cc1cc(N(C)C)c2ccc(N=C(c3ccccc3)c3ccccc3)cc2n1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ TERT O14746 4/20 0.38
▸ CYP1A2 P05177 1/20 0.36
▸ PDGFRB P09619 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ NCF1 P14598 2/20 0.34
▸ ESR1 P03372 1/20 0.34
▸ ESR2 Q92731 1/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ ACP1 P24666 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6790532 0.75 CYP1A2 (0.60) ALDH1A1ADORA2ATERTCYP1A2NCF1
SCHEMBL6617731 0.69 TERT (0.51) ALDH1A1LMNAHTTADORA2ATERT
SCHEMBL6606041 0.68 NQO2 (0.50) LMNAHTTADORA2ATERTKDR
SCHEMBL6600579 0.68 POLB (0.64) TERTMAPT
SCHEMBL6614139 0.68 TERT (0.43) ALDH1A1LMNAHTTADORA2ATERT
SCHEMBL30402030 0.68 ESR1 (0.40) ALDH1A1SMN1; SMN2CYP1A2ESR1ESR2
SCHEMBL20986110 0.67 LMNA (0.49) ALDH1A1LMNASMN1; SMN2PDGFRBKDR
SCHEMBL16992863 0.66 ALDH1A1 (0.46) ALDH1A1LMNAHTTSMN1; SMN2ESR1
SCHEMBL24206815 0.66 CYP1A2 (0.50) ALDH1A1LMNAHTTSMN1; SMN2CYP1A2
SCHEMBL17687644 0.65 MAPT (0.46) ALDH1A1LMNAHTTSMN1; SMN2PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373252-A1 CHEMICAL DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT Aventis Pharma S.A. (FR) 2004-01-02 — — EP disclosed
WO-2002076975-A1 CHEMICAL DERIVATIVES AND THEIR USE AS ANTI-TELOMERASE AGENT AVENTIS PHARMA S.A. (FR) 2002-10-03 — — WO disclosed
Send feedback